Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2000

View Archived Issues

Serine elastase inhibition results in complete reversal of fatal pulmonary hypertension in rats

Methoxsalen shown to reduce smoking by increasing the bioavailability of nicotine

Two human cellular genes necessary for hepatitis C virus growth identified

Clinicians urge review of the cardiotoxicity of trastuzumab

New gene therapy approach shows potential in rat model of Parkinson's

Avanir receives FDA approval for OTC docosanol 10% cream

Genome Therapeutics and Schering-Plough extend alliance on drug-resistant infections

Lexicon establishes functional genomics research collaboration

Antisense candidate for type 2 diabetes identified at Isis

Altropane specific and sensitive in differential diagnosis of PD

Almogran granted wide approval in Europe for migraine

Status of Dermagraft updated; PMA submission expected soon

Funds will be used by ZymeTx to advance development of therapeutics and diagnostics

Intranasal ADNF-related peptides improve performance in a water maze in rats

Viragen signs collaboration for cancer vaccine development

Gliatech's antiproperdin monoclonal antibody assessed in MI model

Rat studies support Cereport as an effective means of enhancing carboplatin delivery

Tetracyclines as a valuable and relatively safe therapy for corneal ulceration

Combined AT1 antagonist and immunosuppressant for GvHD complications

Methods of treating CFS with 5-HT3 antagonists described by Novartis

Anticancer combinations with synergistic activity

Antiviral hexapeptides in fungus discovered at University of California

Recently issued patent covers new compounds for estrogen-related conditions

Roche presents new inhibitors of TNF-alpha release and their potential uses

Antifungal and antiparasitic cyclic peptides described by Lilly

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...